Filing Details

Accession Number:
0001127602-11-012904
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-12 19:32:36
Reporting Period:
2011-04-11
Filing Date:
2011-04-12
Accepted Time:
2011-04-12 19:32:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850693 Allergan Inc AGN Pharmaceutical Preparations (2834) 951622442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190637 F James Barlow 2525 Dupont Drive
Irvine CA 92612
Sr. Vp, Corp. Controller (Pao) No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-04-11 351 $75.09 11,798 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,495 Indirect By 401(k) Trust
Common Stock 639 Indirect By Esop Trust
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 7, 2011.
  2. Shares allocated to reporting person's SIP account as of reporting date.
  3. Shares allocated to the reporting person's ESOP account as of reporting date.